Amiodarone hydrochloride and Blindness - a phase IV clinical study of FDA data

Summary:

Blindness is reported as a side effect among people who take Amiodarone hydrochloride (amiodarone hydrochloride), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Furosemide, and have Lung disorder.

The phase IV clinical study analyzes which people have Blindness when taking Amiodarone hydrochloride. It is created by eHealthMe based on reports of 9,284 people who have side effects when taking Amiodarone hydrochloride from the FDA, and is updated regularly.

What is Amiodarone hydrochloride?

Amiodarone hydrochloride has active ingredients of amiodarone hydrochloride. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 10,061 Amiodarone hydrochloride users. Check the latest studies of Amiodarone hydrochloride.

What is Blindness?

Blindness is found to be associated with 1,507 drugs and 1,990 conditions by eHealthMe. Check the latest studies of Blindness.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jul, 12, 2026

9,284 people reported to have side effects when taking Amiodarone hydrochloride.
Among them, 316 people (3.4%) have Blindness.

Could Amiodarone hydrochloride cause Blindness?

Among these 316 people:

How long have people been on Amiodarone hydrochloride when they have Blindness? *

Click here to view more results

What is the gender of people who have Blindness when taking Amiodarone hydrochloride? *

Click here to view

What is the age of people who have Blindness when taking Amiodarone hydrochloride? *

Click here to view more results

* Approximation only. Some reports may have incomplete information.

Do you take Amiodarone hydrochloride and have Blindness?

- Check whether Blindness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Amiodarone hydrochloride:

Amiodarone hydrochloride (10,061 reports)

Blindness treatments and more:

Blindness (45,948 reports)

How severe was Blindness and when was it recovered:

Blindness in Amiodarone hydrochloride

Expand to all the drugs that have ingredients of amiodarone hydrochloride:

Blindness and drugs with ingredients of amiodarone hydrochloride (767 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Amiodarone hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Blindness:

Blindness (1,507 drugs)

Browse all the conditions that are associated with Blindness:

Blindness (1,990 conditions)

Related publications that referenced our studies

Tesic D, Kostic M, Paunovic D, Jankovic SM, "Analysis of the cost–effectiveness of dronedarone versus amiodarone, propafenone, and sotalol in patients with atrial fibrillation: results for Serbia", Kardiologia Polska (Polish Heart Journal), 2016 Jan .
Kim DJ, Lee SC, Park GS, Kim GJ, Hwang WT, Lee CS, Lee MH, Hahn DH, Koh HC, "Amiodarone Induced Multiorgan Toxicity in a Patient of Hypertrophic Cardiomyopathy With Atrial Fibrillation", Journal of the Korean Geriatrics Society, 2013 Dec .
Tesic D, Kostic M, Paunovic D, Jankovic SM, "Analysis of the cost–effectiveness of dronedarone versus amiodarone, propafenone, and sotalol in patients with atrial fibrillation: results for Serbia", Kardiologia Polska (Polish Heart Journal), 2016 Jan .
Kim DJ, Lee SC, Park GS, Kim GJ, Hwang WT, Lee CS, Lee MH, Hahn DH, Koh HC, "Amiodarone Induced Multiorgan Toxicity in a Patient of Hypertrophic Cardiomyopathy With Atrial Fibrillation", Journal of the Korean Geriatrics Society, 2013 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on amiodarone hydrochloride (the active ingredients of Amiodarone hydrochloride) and Amiodarone hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.